Icahn School of Medicine at Mount Sinai Medical Center, NY, NY; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; RAND Corporation, Santa Monica, CA.
J Am Coll Surg. 2015 Feb;220(2):207-17.e11. doi: 10.1016/j.jamcollsurg.2014.10.021. Epub 2014 Nov 8.
This study aims to describe the magnitude of hospital costs among patients undergoing elective colectomy, cholecystectomy, and pancreatectomy, determine whether these costs relate as expected to duration of care, patient case-mix severity and comorbidities, and whether risk-adjusted costs vary significantly by hospital. Correctly estimating the cost of production of surgical care may help decision makers design mechanisms to improve the efficiency of surgical care.
Patient data from 202 hospitals in the ACS-NSQIP were linked to Medicare inpatient claims. Patient charges were mapped to cost center cost-to-charge ratios in the Medicare cost reports to estimate costs. The association of patient case-mix severity and comorbidities with cost was analyzed using mixed effects multivariate regression. Cost variation among hospitals was quantified by estimating risk-adjusted hospital cost ratios and 95% confidence intervals from the mixed effects multivariate regression.
There were 21,923 patients from 202 hospitals who underwent an elective colectomy (n = 13,945), cholecystectomy (n = 5,569), or pancreatectomy (n = 2,409). Median cost was lowest for cholecystectomy ($15,651) and highest for pancreatectomy ($37,745). Room and board costs accounted for the largest proportion (49%) of costs and were correlated with length of stay, R = 0.89, p < 0.001. The patient case-mix severity and comorbidity variables most associated with cost were American Society of Anesthesiologists (ASA) class IV (estimate 1.72, 95% CI 1.57 to 1.87) and fully dependent functional status (estimate 1.63, 95% CI 1.53 to 1.74). After risk-adjustment, 66 hospitals had significantly lower costs than the average hospital and 57 hospitals had significantly higher costs.
The hospital costs estimates appear to be consistent with clinical expectations of hospital resource use and differ significantly among 202 hospitals after risk-adjustment for preoperative patient characteristics and procedure type.
本研究旨在描述择期结肠切除术、胆囊切除术和胰腺切除术患者的住院费用规模,确定这些费用是否与护理时间、患者病例组合严重程度和合并症的预期相关,以及风险调整后的费用是否因医院而异。正确估计手术护理的生产成本可能有助于决策者设计提高手术护理效率的机制。
将 ACS-NSQIP 中 202 家医院的患者数据与 Medicare 住院索赔相关联。将患者收费映射到 Medicare 成本报告中的成本中心成本收费比,以估算成本。使用混合效应多变量回归分析患者病例组合严重程度和合并症与成本的关系。通过从混合效应多变量回归中估计风险调整后的医院成本比和 95%置信区间,量化医院间的成本差异。
共有 202 家医院的 21923 名患者接受了择期结肠切除术(n=13945)、胆囊切除术(n=5569)或胰腺切除术(n=2409)。胆囊切除术的中位费用最低(15651 美元),胰腺切除术的费用最高(37745 美元)。病房和董事会费用占成本的最大比例(49%),与住院时间呈正相关,R=0.89,p<0.001。与成本最相关的患者病例组合严重程度和合并症变量是美国麻醉师协会(ASA)分级 IV(估计值 1.72,95%CI 1.57 至 1.87)和完全依赖的功能状态(估计值 1.63,95%CI 1.53 至 1.74)。风险调整后,66 家医院的成本明显低于平均水平,57 家医院的成本明显高于平均水平。
医院成本估计似乎与临床对医院资源使用的预期一致,并且在风险调整了术前患者特征和手术类型后,202 家医院之间的差异显著。